These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 19749256)

  • 21. Dissecting RNA-interference pathway with small molecules.
    Chiu YL; Dinesh CU; Chu CY; Ali A; Brown KM; Cao H; Rana TM
    Chem Biol; 2005 Jun; 12(6):643-8. PubMed ID: 15975509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Derivation and function of small interfering RNAs and microRNAs.
    Cullen BR
    Virus Res; 2004 Jun; 102(1):3-9. PubMed ID: 15068874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nucleocytoplasmic transport of microRNAs and related small RNAs.
    Katahira J; Yoneda Y
    Traffic; 2011 Nov; 12(11):1468-74. PubMed ID: 21518166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combinatorial delivery of small interfering RNAs reduces RNAi efficacy by selective incorporation into RISC.
    Castanotto D; Sakurai K; Lingeman R; Li H; Shively L; Aagaard L; Soifer H; Gatignol A; Riggs A; Rossi JJ
    Nucleic Acids Res; 2007; 35(15):5154-64. PubMed ID: 17660190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of Novel Antisense Oligonucleotides for the Functional Regulation of RNA-Induced Silencing Complex (RISC) by Promoting the Release of microRNA from RISC.
    Ariyoshi J; Momokawa D; Eimori N; Kobori A; Murakami A; Yamayoshi A
    Bioconjug Chem; 2015 Dec; 26(12):2454-60. PubMed ID: 26471458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SiRNAs conjugated with aromatic compounds induce RISC-mediated antisense strand selection and strong gene-silencing activity.
    Kubo T; Yanagihara K; Takei Y; Mihara K; Sato Y; Seyama T
    Biochem Biophys Res Commun; 2012 Oct; 426(4):571-7. PubMed ID: 22982308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modification of the siRNA passenger strand by 5-nitroindole dramatically reduces its off-target effects.
    Zhang J; Zheng J; Lu C; Du Q; Liang Z; Xi Z
    Chembiochem; 2012 Sep; 13(13):1940-5. PubMed ID: 22887813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modified siRNAs for the study of the PAZ domain.
    Somoza A; Terrazas M; Eritja R
    Chem Commun (Camb); 2010 Jun; 46(24):4270-2. PubMed ID: 20485810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design of nuclease-resistant fork-like small interfering RNA (fsiRNA).
    Chernolovskaya EL; Zenkova MA
    Methods Mol Biol; 2013; 942():153-68. PubMed ID: 23027050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of siRNAs that contain internal variable-length spacer linkages.
    Efthymiou TC; Peel B; Huynh V; Desaulniers JP
    Bioorg Med Chem Lett; 2012 Sep; 22(17):5590-4. PubMed ID: 22850216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-cell-autonomous effects of vector-expressed regulatory RNAs in mammalian heart cells.
    Kizana E; Cingolani E; Marbán E
    Gene Ther; 2009 Sep; 16(9):1163-8. PubMed ID: 19516277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of RISC-associated adenoviral small RNAs.
    Xu N; Akusjärvi G
    Methods Mol Biol; 2011; 721():183-98. PubMed ID: 21431686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Small RNA asymmetry in RNAi: function in RISC assembly and gene regulation.
    Hutvagner G
    FEBS Lett; 2005 Oct; 579(26):5850-7. PubMed ID: 16199039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Small molecule inhibition of RISC loading.
    Tan GS; Chiu CH; Garchow BG; Metzler D; Diamond SL; Kiriakidou M
    ACS Chem Biol; 2012 Feb; 7(2):403-10. PubMed ID: 22026461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Solid-phase synthesis of modified RNAs containing amide-linked oligoribonucleosides at their 3'-end and their application to siRNA.
    Iwase R; Toyama T; Nishimori K
    Nucleosides Nucleotides Nucleic Acids; 2007; 26(10-12):1451-4. PubMed ID: 18066804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improvement of RNAi activity and strand selectivity of RISC formation by modified siRNA involving intercalators near 5' termini.
    Ito H; Urushihara M; Liang X; Asanuma H
    Chembiochem; 2012 Jan; 13(2):311-5. PubMed ID: 22213122
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of siRNA with an asymmetric RNA/dTdT overhang on RNA interference activity.
    Park JH; Hong SW; Yun S; Lee DK; Shin C
    Nucleic Acid Ther; 2014 Oct; 24(5):364-71. PubMed ID: 25211666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effective Anti-miRNA Oligonucleotides Show High Releasing Rate of MicroRNA from RNA-Induced Silencing Complex.
    Ariyoshi J; Matsuyama Y; Kobori A; Murakami A; Sugiyama H; Yamayoshi A
    Nucleic Acid Ther; 2017 Oct; 27(5):303-308. PubMed ID: 28876213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Competition for RISC binding predicts in vitro potency of siRNA.
    Koller E; Propp S; Murray H; Lima W; Bhat B; Prakash TP; Allerson CR; Swayze EE; Marcusson EG; Dean NM
    Nucleic Acids Res; 2006; 34(16):4467-76. PubMed ID: 16945958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative aspects of RNA silencing in metazoans.
    Sergeeva AM; Pinzón Restrepo N; Seitz H
    Biochemistry (Mosc); 2013 Jun; 78(6):613-26. PubMed ID: 23980888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.